Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type

New England Journal of Medicine

Volumn 334, Issue 19, 1996, Pages 1222-1230

  Stanley, Sharilyn K ^a   Ostrowski, Mario A ^a   Justement, Jesse S ^a   Gantt, Kira ^a   Hedayati, Susan ^a   Mannix, Margaret ^b   Roche, Kim ^a   Schwartzentruber, Douglas J ^c   Fox, Cecil H ^d   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Molecular Histology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXOID; VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; BODY BURDEN; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOSTIMULATION; INFECTION SENSITIVITY; LYMPH NODE BIOPSY; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIREMIA; VIRUS EXPRESSION; VIRUS ISOLATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, SECONDARY; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; TETANUS TOXOID; VIREMIA; VIRUS ACTIVATION;

EID: 0029979690     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/nejm199605093341903     Document Type: Article

References (31)

1. Fauci AS, Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993;262:1011-8.
2. Zagury D, Bernard J, Leonard R, et al. Long-term cultures of HTLV-III-infected T cells, a model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850-3.
3. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7
4. Rosenberg ZF, Fauci AS. Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses 1989;5:1-4
5. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure Cell 1990;61:213-22.
6. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-7.
7. Folks T, Kelly J, Benn S, et al. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV J Immunol 1986,136.4049-53.
8. Popov J, McGraw T, Hofmann B, et al Acute lymphoid changes and ongoing immune activation in SIV infection. J Acquir Immune Defic Syndr 1992;5.391-9.
9. Fultz PN, Gluckman JC, Muchmore E, Girard M. Transient increases in numbers of infectious cells in an HIV-1 infected chimpanzee following immune stimulation AIDS Res Hum Retroviruses 1992;8:313-7.
10. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
11. Claydon EJ, Bennett J, Gor D, Forster SM. Transient elevation of serum HIV antigen levels associated with intercurrent infection. AIDS 1991;5:113-4.
12. Ho DD. HIV-1 viraemia and influenza. Lancet 1992,339:1549.
13. Schwiebert R, Fultz PN. Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events. J Virol 1994;68:5538-47.
14. Staprans SI, Hamilton BL, Follansbee SE, et al Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995;182:1727-37
15. Quinn TC, Piot P, McCormick JB, et al. Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA 1987;257:2617-21.
16. Nagelkerke NJ, Plummer FA, Holton D, et al. Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. AIDS 1990;4:743-7.
17. Colebunders RL, Latif AS. Natural history and clinical presentation of HIV-1 infection in adults. AIDS 1991;5:Suppl 1:S103-S112.
18. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Who will get AIDS? Lancet 1986;2:1216-7.
19. Bentwich Z, Kalinkovich A, Weisman Z Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
20. Janoff EN, Hardy WD, Smith PD, Wahl SM. Humoral recall responses in HIV infection: levels, specificity, and affinity of antigen-specific IgG. J Immunol 1991;147:2130-5.
21. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS Qualitative analysis of immune function m patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
22. Willey RL, Smith DH, Lasky LA, et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62 139-47
23. Stanley SK, McCune JM, Kaneshima H, et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse J Exp Med 1993,178:1151-63
24. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction J Clin Microbiol 1992;30:1752-7.
25. Brichacek B, Swindells S, Janoff E, Stevenson M Immune activation and control of viral burden in AIDS In: Program and abstracts of the Second National Conference on Human Retroviruses and Related Infection, Washington, DC., January 29-February 2, 1995. Washington, DC . American Society for Microbiology, 1995:98 abstract
26. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 1995;373.123-6.
27. Wei X, Ghosh SK, Taylor ME, et al Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373 117-22.
28. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993,362355-8
29. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophases by HIV during the incubation period of AIDS Nature 1993,362 359-62
30. Burke AP, Anderson D, Mannan P, et al Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome Hum Pathol 1994,25 248-56.
31. Cohen OJ, Pantaleo G, Holodmy M, et al. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue Proc Natl Acad Sci U S A 1995,92 6017-21